RBRXF — Rhino Biotech Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual balance sheet for Rhino Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2016 December 31st	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.021	0.004	0.002	0.002	0.001
Prepaid Expenses
Total Current Assets	0.021	0.004	0.002	0.002	0.001
Total Assets	0.021	0.004	0.002	0.002	0.001
Payable / Accrued
Notes Payable / Short Term Debt
Total Current Liabilities	0.003	0.009	0.005	0.003	0.004
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	0.003	0.009	0.021	0.041	0.062
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.018	-0.005	-0.019	-0.039	-0.06
Total Liabilities & Shareholders' Equity	0.021	0.004	0.002	0.002	0.001
Total Common Shares Outstanding